• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (45)  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in this journal  Social Bookmarking   What's this?

Comparison of African American With White Subjects—Atherosclerosis Risk in Communities Study

Atsushi Hozawa, MD, PhD; Aaron R. Folsom, MD; A. Richey Sharrett, MD, DrPH; Lloyd E. Chambless, PhD

Arch Intern Med. 2007;167(6):573-579.

Background  Among white Americans, a large proportion of cardiovascular disease (CVD) events is explained by borderline or any elevated CVD risk factor levels. The degree to which this is true among African American subjects is unclear.

Methods  The Atherosclerosis Risk in Communities Study included 14 162 middle-aged adults who were free of recognized stroke or coronary heart disease and had baseline information on risk factors. Based on national guidelines, we categorized risk factors (blood pressure, cholesterol levels, diabetes, and smoking) into 3 categories, ie, optimal, borderline, and elevated. Incidence of CVD (composite of stroke and coronary heart disease) (n = 1492) and CVD mortality (n = 612) were identified for a 13-year period.

Results  The proportion of subjects with all optimal risk factor levels was lower in African American (3.8%) than in white (7.5%) subjects. Conversely, the proportion of subjects with at least 1 elevated risk factor was higher in African American (approximately 80%) than in white (approximately 60%) subjects. After adjustment for these risk factor differences and education level, African American and white subjects had virtually identical rates of CVD (relative hazard for African American subjects, 1.01; 95% confidence interval, 0.90-1.14). The proportion of CVD events explained by elevated risk factors was high in African American subjects (approximately 90%) compared with approximately 65% in white subjects.

Conclusions  The higher CVD incidence rate in African American than in white subjects seems largely attributable to a high frequency of elevated CVD risk factors in African American subjects. Primary prevention of elevated CVD risk factors in African American subjects might greatly reduce CVD occurrence as much as it has for white subjects.

Author Affiliations: Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis (Drs Hozawa and Folsom); Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Md (Dr Sharrett); Department of Biostatistics, University of North Carolina, Chapel Hill (Dr Chambless); and Division of Epidemiology, Department of Public Health and Forensic Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Dr Hozawa).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Low Prevalence of Individuals With Optimal or Borderline Levels of Cardiovascular Risk Factors Extends to Rapidly Developing Countries
Pascal Bovet, Julita William, and Fred Paccaud
Arch Intern Med. 2007;167(20):2262-2263.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Low Risk—and the "No More Than 50%" Myth/Dogma
Jeremiah Stamler
Arch Intern Med. 2007;167(6):537-539.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association
Writing Group Members et al.
Circulation 2012;125:e2-e220.
FULL TEXT  

Racial-Ethnic Disparities in Stroke Care: The American Experience: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Cruz-Flores et al.
Stroke 2011;42:2091-2116.
ABSTRACT | FULL TEXT  

Relationship of blood pressure and obesity with inflammatory cytokines among African Americans
DeLoach et al.
Ther Adv Cardiovasc Dis 2011;5:149-157.
ABSTRACT  

Community Prevalence of Ideal Cardiovascular Health, by the American Heart Association Definition, and Relationship With Cardiovascular Disease Incidence
Folsom et al.
J Am Coll Cardiol 2011;57:1690-1696.
ABSTRACT | FULL TEXT  

Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study
Huxley et al.
Circulation 2011;123:1501-1508.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2011 Update: A Report From the American Heart Association
Roger et al.
Circulation 2011;123:e18-e209.
FULL TEXT  

Geographic and Demographic Variability in 20-Year Hypertension Incidence: The CARDIA Study
Levine et al.
Hypertension 2011;57:39-47.
ABSTRACT | FULL TEXT  

Gene-Environment Interaction for Hypertension Among African American Women Across Generations
Taylor et al.
Biol Res Nurs 2010;12:149-155.
ABSTRACT  

Thrombin Stimulation of Proteoglycan Synthesis in Vascular Smooth Muscle Is Mediated by Protease-activated Receptor-1 Transactivation of the Transforming Growth Factor {beta} Type I Receptor
Burch et al.
J. Biol. Chem. 2010;285:26798-26805.
ABSTRACT | FULL TEXT  

Socio-economic disparities in heart disease in the Republic of Lebanon: findings from a population-based study
Ramahi et al.
Heart Asia 2010;2:67-72.
ABSTRACT | FULL TEXT  

Overtime work and incident coronary heart disease: the Whitehall II prospective cohort study
Virtanen et al.
Eur Heart J 2010;31:1737-1744.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association
WRITING GROUP MEMBERS et al.
Circulation 2010;121:e46-e215.
FULL TEXT  

Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond
Lloyd-Jones et al.
Circulation 2010;121:586-613.
ABSTRACT | FULL TEXT  

Vitamin D, Race, and Cardiovascular Mortality: Findings From a National US Sample
Fiscella and Franks
Ann Fam Med 2010;8:11-18.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
WRITING GROUP MEMBERS et al.
Circulation 2009;119:e21-e181.
FULL TEXT  

Prevalence and Progression of Subclinical Atherosclerosis in Younger Adults With Low Short-Term but High Lifetime Estimated Risk For Cardiovascular Disease: The Coronary Artery Risk Development in Young Adults Study and Multi-Ethnic Study of Atherosclerosis
Berry et al.
Circulation 2009;119:382-389.
ABSTRACT | FULL TEXT  

Absolute and Attributable Risks of Heart Failure Incidence in Relation to Optimal Risk Factors
Folsom et al.
Circ Heart Fail 2009;2:11-17.
ABSTRACT | FULL TEXT  

The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering: Prevalence and Correlates of 2 Phenotypes Among the US Population (NHANES 1999-2004)
Wildman et al.
Arch Intern Med 2008;168:1617-1624.
ABSTRACT | FULL TEXT  

Ethnic Group Disparities in 10-Year Trends in Stroke Incidence and Vascular Risk Factors: The South London Stroke Register (SLSR)
Heuschmann et al.
Stroke 2008;39:2204-2210.
ABSTRACT | FULL TEXT  

Why traumatic leg amputees are at increased risk for cardiovascular diseases
Naschitz and Lenger
QJM 2008;101:251-259.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Writing Group Members et al.
Circulation 2008;117:e25-e146.
FULL TEXT  

Low Prevalence of Individuals With Optimal or Borderline Levels of Cardiovascular Risk Factors Extends to Rapidly Developing Countries
Bovet et al.
Arch Intern Med 2007;167:2262-2263.
FULL TEXT  

Chapter 1: Introduction
European Journal of Cardiovascular Prevention & Rehabilitation 2007;14:S2-S113.
FULL TEXT  

How Much Do Risk Factors Explain CVD Incidence Among Blacks and Whites?
JWatch General 2007;2007:5-5.
FULL TEXT  

Low Risk--and the "No More Than 50%" Myth/Dogma
Stamler
Arch Intern Med 2007;167:537-539.
FULL TEXT